Boston Scientific Cardiac Cryoablation System

DEVICE4 trials

Sponsors

Boston Scientific Corporation

Conditions

Atrial FibrillationParoxysmal Atrial Fibrillation

Unknown Phase

Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation

CompletedNCT04133168

Boston Scientific CorporationParoxysmal Atrial Fibrillation

Start: 2020-06-24End: 2023-08-17Updated: 2025-04-03

POLARx Cardiac Cryoablation System Study

CompletedNCT04250714

Boston Scientific CorporationAtrial Fibrillation

Start: 2020-08-06End: 2022-09-26Updated: 2025-04-04

POLARx™ Cardiac Cryoablation System Post Market Clinical Study (POLAR SMART)

CompletedNCT05282823

Boston Scientific CorporationParoxysmal Atrial Fibrillation

Start: 2022-08-26End: 2024-10-29Updated: 2025-12-02

POLARx Post Approval Study (POLARx PAS)

CompletedNCT06170606

Boston Scientific CorporationParoxysmal Atrial Fibrillation

Start: 2024-06-28End: 2026-05-20Updated: 2026-07-27

Related Papers

One‐year outcomes of pulmonary vein isolation with a novel cryoballoon: Primary results of the FROZEN AF trial

Journal of Cardiovascular Electrophysiology2024-03-0617 citations

Acute procedural efficacy and safety of a novel cryoballoon for the treatment of paroxysmal atrial fibrillation: Results from the POLAR ICE study

Journal of Cardiovascular Electrophysiology2023-02-1422 citations

Acute procedural characteristics, efficacy, and safety of a novel cryoballoon for the treatment of paroxysmal atrial fibrillation: Results from the POLAR-ICE study

EP Europace2022-05-181 citations

Biophysical parameters and time to isolation of pulmonary veins with a novel cryoballoon: results of POLAR ICE study

EP Europace2022-05-181 citations